These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 9816534

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Nuclear localization of basic fibroblast growth factor is mediated by heparan sulfate proteoglycans through protein kinase C signaling.
    Hsia E, Richardson TP, Nugent MA.
    J Cell Biochem; 2003 Apr 15; 88(6):1214-25. PubMed ID: 12647303
    [Abstract] [Full Text] [Related]

  • 43. Colony-stimulating factor in middle ear cholesteatoma.
    Huang T, Yan SD, Huang CC.
    Am J Otolaryngol; 1989 Apr 15; 10(6):393-8. PubMed ID: 2688444
    [Abstract] [Full Text] [Related]

  • 44. Basic fibroblast growth factor (FGF) promotes cartilage repair in vivo.
    Cuevas P, Burgos J, Baird A.
    Biochem Biophys Res Commun; 1988 Oct 31; 156(2):611-8. PubMed ID: 3190672
    [Abstract] [Full Text] [Related]

  • 45. [Immunohistochemical studies of vascularization of cholesteatoma].
    Stammberger M, Holly A, Bujia J.
    Laryngorhinootologie; 1993 Apr 31; 72(4):170-3. PubMed ID: 7684226
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. [The significance of keratinocyte in hyperproliferation of middle ear cholesteatoma].
    Zhu Z, Hong Y, Wang Y, He G, Ye S.
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jan 31; 30(2):139-43. PubMed ID: 27192911
    [Abstract] [Full Text] [Related]

  • 48. Platelet-derived growth factor (BB homodimer), transforming growth factor-beta 1, and basic fibroblast growth factor in dermal wound healing. Neovessel and matrix formation and cessation of repair.
    Pierce GF, Tarpley JE, Yanagihara D, Mustoe TA, Fox GM, Thomason A.
    Am J Pathol; 1992 Jun 31; 140(6):1375-88. PubMed ID: 1376557
    [Abstract] [Full Text] [Related]

  • 49. [Immunohistochemical basement membrane analysis of cholesteatoma epithelium].
    Lang S, Nerlich A, Wiest I, Schreiner M.
    Laryngorhinootologie; 1994 Jul 31; 73(7):371-4. PubMed ID: 7916782
    [Abstract] [Full Text] [Related]

  • 50. [Proliferation behavior of cholesteatoma].
    Hoppe F.
    HNO; 1995 Dec 31; 43(12):710-5. PubMed ID: 8582830
    [Abstract] [Full Text] [Related]

  • 51. Humoral control of cell proliferation: the role of fibroblast growth factor in regeneration, angiogenesis, wound healing, and neoplastic growth.
    Gospodarowicz D.
    Prog Clin Biol Res; 1976 Dec 31; 9():1-19. PubMed ID: 1030795
    [Abstract] [Full Text] [Related]

  • 52. [Ultrastructural aspects of cholesteatoma of the middle ear].
    Paludetti G, Almadori G, Ottaviani F, Rosignoli M, Rossodivita M, D'Alatri L.
    Acta Otorhinolaryngol Ital; 1989 Dec 31; 9(2):169-80. PubMed ID: 2763842
    [Abstract] [Full Text] [Related]

  • 53. Correlation of cholesteatomas perimatrix thickness with patient's age.
    Dornelles C, da Costa SS, Meurer L, Schweiger C.
    Braz J Otorhinolaryngol; 2005 Dec 31; 71(6):792-7. PubMed ID: 16878250
    [Abstract] [Full Text] [Related]

  • 54. Histochemical demonstration of mucin in lymphatic vessels of human middle ear cholesteatoma.
    Nagai T, Suganuma T, Ide S, Morimitsu T.
    Eur Arch Otorhinolaryngol; 1993 Dec 31; 250(4):233-6. PubMed ID: 8396397
    [Abstract] [Full Text] [Related]

  • 55. Role of Bcl-xL protein in differentiation and apoptosis of human middle ear cholesteatoma epithelium.
    Kojima H, Miyazaki H, Tanaka Y, Shiwa M, Koga T, Moriyama H.
    Arch Otolaryngol Head Neck Surg; 1999 Jul 31; 125(7):738-42. PubMed ID: 10406309
    [Abstract] [Full Text] [Related]

  • 56. Induction of matrix metalloproteinases in keratinocytes by cholesteatoma debris and granulation tissue extracts.
    Schmidt M, Grünsfelder P, Hoppe F.
    Eur Arch Otorhinolaryngol; 2000 Jul 31; 257(8):425-9. PubMed ID: 11073191
    [Abstract] [Full Text] [Related]

  • 57. Platelet-derived growth factor in middle ear cholesteatoma.
    Fujioka O, Huang CC.
    Eur Arch Otorhinolaryngol; 1994 Jul 31; 251(4):199-204. PubMed ID: 7917251
    [Abstract] [Full Text] [Related]

  • 58. Sialomucin in middle ear cholesteatoma perimatrix.
    Nagai T, Kawano J, Suganuma T.
    Acta Otolaryngol; 1992 Jul 31; 112(4):686-90. PubMed ID: 1279931
    [Abstract] [Full Text] [Related]

  • 59. Induction of keratinocyte growth factor expression is reduced and delayed during wound healing in the genetically diabetic mouse.
    Werner S, Breeden M, Hübner G, Greenhalgh DG, Longaker MT.
    J Invest Dermatol; 1994 Oct 31; 103(4):469-73. PubMed ID: 7930669
    [Abstract] [Full Text] [Related]

  • 60. Bioglass Activated Skin Tissue Engineering Constructs for Wound Healing.
    Yu H, Peng J, Xu Y, Chang J, Li H.
    ACS Appl Mater Interfaces; 2016 Jan 13; 8(1):703-15. PubMed ID: 26684719
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.